STOCK TITAN

MITESCO INC - MITI STOCK NEWS

Welcome to our dedicated page for MITESCO news (Ticker: MITI), a resource for investors and traders seeking the latest updates and insights on MITESCO stock.

Mitesco, Inc. (symbol: MITI) is a development stage company dedicated to consolidating businesses within the compound pharmacy industry, serving human and veterinary markets. Beginning its operations in the Southeast, Mitesco aims to acquire compounders across the United States that align with its mission and vision. The company is committed to unlocking the potential of the compounding pharmacy sector to improve both human and animal health, meet unmet patient needs, enhance the dignity of skilled pharmacists, and build shareholder value through providing quality, cost-effective, and innovative healthcare products and pharmaceuticals worldwide.

Mission: To unlock the potential of the compounding pharmacy industry, improve health outcomes, and provide innovative healthcare solutions while building shareholder value.

Vision: To be globally recognized for best practices in quality, efficiency, and sustainability within the compounding pharmaceutical industry.

Recent Achievements & Current Projects:

  • Full compliance with reporting requirements, including the completion of the Annual Report on Form 10-K.
  • Engagement of Accell Group as their auditor to support compliance and review records effectively.
  • Institutional investors' continued support through 12-month notes to secure funding needs.
  • Ongoing evaluation of the company's capital structure to support both historical and new investors.
  • Formation of a new Advisory Board to assist in evaluating potential acquisition candidates, including both private and publicly held entities.
  • Strategic focus on technology, service, and product business candidates, with a view towards distributing dividends to shareholders from spin-outs.

Financial Condition: Mitesco is actively managing its financial structure, including the termination of a prior stock option program, cancellation of a reverse stock split, and adjustment of restricted stock dividends to protect common stockholders' interests.

Partnerships: Collaboration with Accell Group and support from institutional investors have been crucial in advancing Mitesco's key initiatives and compliance activities.

Future Prospects: With a strategy focused on both organic and acquisition growth, Mitesco aims to leverage its expertise in startups and turnarounds to create successful growth situations. The company is also exploring new initiatives in the data center market and cyber security services, intending to enter commercial, governmental, and utility markets.

Conclusion: Mitesco's dedication to providing high-quality, accessible, and affordable healthcare solutions underscores its potential to become a leading player in the compounding pharmacy industry. By focusing on quality, efficiency, and sustainability, Mitesco is positioned for long-term growth and shareholder value creation.

Rhea-AI Summary

Mitesco, Inc. (OTCQB: MITI) reported a significant increase in its net loss for 2021, amounting to $11.2 million, or $(.06) per share, on revenue of $116,000, up from a loss of $2.9 million in 2020. The revenue stemmed from three new clinics opened during the year. Operating expenses rose by $3.5 million, influenced by increased Preferred Stock dividends. Despite challenges, the company plans to open 14 to 20 additional clinics in 2022, aiming for breakeven in Minnesota by year-end 2023. Cash on hand improved to $1.2 million, with a successful focus on expanding its clinic network.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.5%
Tags
-
Rhea-AI Summary

Mitesco, Inc. (OTCQB: MITI) will host a shareholder update conference call on March 8, 2022, at 4:15 p.m. ET, led by CEO Larry Diamond. The call will cover the company's expansion plans, the intention to uplist to Nasdaq, and increased activity in existing clinics. Participants can join via a webcast link or by dialing in. A replay will be available until March 22, 2022. Mitesco aims to enhance healthcare accessibility through its subsidiary, The Good Clinic, utilizing a nurse practitioner model.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary

Mitesco, Inc. (OTCQB: MITI) has appointed Ms. Jessica Finnegan as Vice President of Human Resources. Finnegan brings over two decades of global HR experience, previously serving as Chief Human Resources Officer at MKS2 Technologies, where she managed HR for employees across 49 states. Her extensive background includes high-level positions in organizations like Global Aerospace Logistics and the US Department of Defense. CEO Larry Diamond emphasized her role as crucial for the company’s growth, especially as Mitesco expands its clinic operations and prepares for a Nasdaq uplisting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
Rhea-AI Summary

Mitesco, Inc. (OTCQB: MITI) will host a shareholder update meeting on November 22, 2021, at 11:30 a.m. ET. CEO Larry Diamond will present the company's growth plans, market opportunities, and progress. Participants can join via webcast or dial-in. The event aims to provide insights into Mitesco's innovative approach to healthcare through personalized wellness clinics. The company emphasizes accessible, high-quality, and affordable healthcare solutions through its subsidiary, The Good Clinic, and future European operations under Acelerar Healthcare Holdings Limited.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences
-
Rhea-AI Summary

Mitesco, Inc. (OTCQB: MITI), a wellness clinic operator, reports significant progress in expanding its network of The Good Clinic™ locations. The company opened three clinics in Minneapolis and plans to operate eight by spring 2022, aiming for 50 clinics by the end of 2023. Mitesco has secured necessary funding from institutional investors and management, reflecting strong commitment to growth. However, revenue generation has been slow, though increasing client traffic and insurance partnerships are expected to boost earnings in the future.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4%
Tags
none
-
Rhea-AI Summary

Mitesco, Inc. (OTCQB: MITI) has unveiled a series of informational video interviews showcasing its leadership team from The Good Clinic, LLC. The initiative aims to educate current and potential investors about Mitesco’s patient-focused healthcare model and the integration of technology in primary care.

CEO Larry Diamond highlighted that increasing inquiries from investors prompted this proactive approach to enhance communication. The initial video features insights from Board Chair Tom Brodmerkel and leadership members Michael Howe and Brad Case.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.67%
Tags
management
Rhea-AI Summary

Mitesco, Inc. (OTCQB: MITI) has announced the lease of its sixth wellness clinic site in Eagan, Minnesota, near the new Minnesota Vikings training facility. CEO Larry Diamond highlighted the strategic location's potential to attract a new client base due to the area's growth in residential developments. Eagan, a thriving city with over 67,000 residents, boasts a robust business environment, making it an ideal choice for Mitesco's expansion. The company continues to build a network of clinics focusing on personalized care and enhanced accessibility.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Mitesco, Inc. (OTCQB: MITI) has secured a lease for its fifth Twin Cities Good Clinic™ location in Maple Grove, a rapidly growing area in Minnesota. This clinic is part of the company’s expansion strategy to open a total of seven clinics in the Minneapolis–Saint Paul and Denver areas by the end of 2021. The Maple Grove site is ideally located near communities with a high concentration of potential patients. The Good Clinic aims to enhance healthcare accessibility through technology and personalized care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.85%
Tags
none
-
Rhea-AI Summary

Mitesco, Inc. (OTCQB: MITI) has announced the signing of a lease for its second Denver location of The Good Clinic, situated at The Quincy in Downtown Denver. This expansion aims to establish a long-term client base in a rapidly growing labor market. The new location, expected to operate by Q1 2022, will complement Mitesco's growth strategy alongside its existing Minneapolis site. The Quincy features luxury apartments and retail space, enhancing the clinic's visibility and accessibility in the region.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Mitesco, Inc. (OTCQB: MITI) announced the opening of its third The Good Clinic location in St. Louis Park, Minnesota, enhancing whole-person healthcare in the area. CEO Larry Diamond emphasized the community's diverse population and valuable resources as key reasons for the clinic's establishment. The new site is part of a network expansion, following the recent openings in Northeast Minneapolis and Eden Prairie. Mitesco plans to further extend operations in Minnesota and Colorado, aiming to provide tech-forward healthcare services with nurse practitioners as primary providers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of MITESCO (MITI)?

The current stock price of MITESCO (MITI) is $0.4 as of December 24, 2024.

What is the market cap of MITESCO (MITI)?

The market cap of MITESCO (MITI) is approximately 3.5M.

What does Mitesco, Inc. do?

Mitesco, Inc. consolidates businesses in the compound pharmacy industry, serving both human and veterinary markets.

Where is Mitesco, Inc. starting its operations?

Mitesco is beginning its operations in the Southeast and intends to acquire compounders across the United States.

What is Mitesco's mission?

Mitesco's mission is to unlock the potential of the compounding pharmacy industry to improve health outcomes and provide innovative healthcare solutions.

Who is Mitesco's new auditor?

Mitesco has engaged the Accell Group as their new auditor.

What recent financial adjustments has Mitesco made?

Mitesco has terminated a prior stock option program, cancelled a reverse stock split, and adjusted restricted stock dividends.

What will Mitesco's new Advisory Board focus on?

The new Advisory Board will assist in evaluating potential acquisition candidates and exploring both private and publicly held entities.

What new market is Mitesco exploring?

Mitesco is exploring new initiatives in the data center market and cyber security services.

How is Mitesco managing its capital structure?

Mitesco is evaluating its capital structure, including securing funding through 12-month notes and considering changes to support all investors.

What is Mitesco's vision?

Mitesco aims to be globally recognized for best practices in quality, efficiency, and sustainability within the compounding pharmaceutical industry.

Who supports Mitesco financially?

Mitesco is supported by institutional investors and has engaged Accell Group for auditing and compliance support.

MITESCO INC

OTC:MITI

MITI Rankings

MITI Stock Data

3.47M
8.09M
10.9%
0.07%
Health Information Services
Healthcare
Link
United States of America
Vero Beach